Product name: Tirzepatide
Short name: Rapid fat loss
Concentration: 5mg
Suggested diluent: Bacteriostatic water
Product summary:
Tirzepatide (marketed as Mounjaro for type 2 diabetes and Zepbound for obesity) is a once-weekly, subcutaneous dual GIP/GLP-1 receptor agonist that improves blood sugar control and induces significant weight loss. It works by increasing insulin release, reducing glucagon, and slowing gastric emptying. Common side effects include nausea, vomiting, and diarrhea, particularly when increasing doses.
